Skip to main content

Table 3 Associations of vascular measurements (FMD, NMD and PWV) with categorical parameters

From: Determinants of vascular function in patients with type 2 diabetes

  FMD, % P NMD, % P PWV, m/sec P
Gender
Male, n = 49 1.92 ± 1.56   10.32 ± 4.52   10.62 ± 2.54  
Female, n = 116 2.00 ± 1.71 0.772 9.99 ± 3.51 0.648 10.02 ± 2.09 0.181
Smoking
Yes, n = 28 2.01 ± 1.47   10.33 ± 4.07   10.31 ± 2.58  
No, n = 137 1.97 ± 1.70 0.900 10.04 ± 3.80 0.720 10.16 ± 2.18 0.793
Hypertension
Yes, n = 131 1.93 ± 1.65   9.58 ± 3.58   10.47 ± 2.24  
No, n = 34 2.14 ± 1.73 0.528 12.05 ± 4.19 0.001 9.25 ± 1.98 0.009
Antihypertensive medications
Yes, n = 109 1.84 ± 1.64   9.09 ± 3.33   10.54 ± 2.12  
No, n = 56 2.24 ± 1.68 0.143 12.03 ± 4.05 <0.001 9.57 ± 2.31 0.019
Hypercholesterolemia
Yes, n = 150 1.94 ± 1.65   10.03 ± 3.86   10.19 ± 2.24  
No, n = 15 2.29 ± 1.77 0.441 10.63 ± 3.66 0.565 10.11 ± 2.23 0.911
Statins
Yes, n = 48 1.99 ± 1.65   9.88 ± 3.91   10.57 ± 2.45  
No, n = 117 1.97 ± 1.67 0.951 10.17 ± 3.82 0.656 10.01 ± 2.12 0.199
Insulin treatment
Yes, n = 36 1.53 ± 1.66   8.65 ± 3.01   11.12 ± 2.72  
No, n = 129 2.10 ± 1.65 0.066 10.49 ± 3.95 0.004 9.97 ± 2.06 0.059
  1. FMD, flow-mediated dilation of the brachial artery; NMD, nitrate-mediated dilation of the brachial artery; PWV, carotid-femoral pulse wave velocity.